arrow
C

Cristina Díaz de Heredia

hospital universitari vall d'hebron
H指数:43
被引数:6,501

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Total body irradiation versus chemotherapy before stem cell transplantation in children aged two to four with acute lymphoblastic leukemia—an EBMT pediatric diseases working party study

儿童急性淋巴细胞白血病2至4岁患者造血干细胞移植前全身照射与化疗的比较——EBMT儿科疾病工作组研究

Leukemia
IF13.4
2026-08-210
OA
Sinusoidal obstruction syndrome in children with B‐acute lymphoblastic leukemia (B‐ALL) treated with inotuzumab ozogamicin: Results from the ITCC‐059 trial

窦性阻塞综合征在用伊诺妥单抗奥佐米星治疗B-急性淋巴细胞白血病(B-ALL)的儿童中的发生情况:ITCC-059试验结果

2026-08-210
OAAI
The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMT

儿童急性髓系白血病异基因造血细胞移植中移植前髓外疾病对预后的影响——代表PDWP/EBMT

2026-05-190
PRE
Third Allogeneic Stem Cell Transplantation in Children: A Multicenter Analysis From the Spanish GETH-TC Pediatric Group

第三次同种异基因干细胞移植在儿童中的研究:西班牙GETH-TC儿科组的多中心分析

2026-01-010
OAAI
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM trial

FORUM试验中微量残留病对儿童急性淋巴细胞白血病造血干细胞移植结局的影响

2026-01-011
OA
Outcome of children with B-cell acute lymphoblastic leukemia with hypodiploidy or BCR::ABL1 fusion undergoing allogeneic HSCT: results from the prospective FORUM study

低倍体或BCR::ABL1融合的B细胞急性淋巴细胞白血病儿童接受 allo HSCT 的结局:前瞻性FORUM研究的结果

Blood
IF23.1
2025-11-280
PRE
Unrelated donor transplantation offers a real curative opportunity for patients with transfusion-dependent thalassaemia. A multicenter retrospective study on behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

无关供者移植为依赖输血的地中海贫血患者提供了真正的治愈机会。一项代表西班牙造血移植与细胞治疗组(GETH-TC)的多中心回顾性研究。

2025-10-010
PRE
Non-neurological, non skeletal outcomes after hematopoietic stem and progenitor cell-gene therapy -OTL-203- for Hurler syndrome

非神经性、非骨骼结局:用于Hurler综合征的造血干细胞及祖细胞-基因疗法-OTL-203

2025-09-270
PRE
The use of mesenchymal stromal cells in steroid-refractory graft-versus-host disease after pediatric hematopoietic stem cell transplantation: a report of the Spanish group of stem cell transplantation (Geth)

间充质基质细胞在儿童造血干细胞移植后糖皮质激素难治性移植物抗宿主病中的应用:西班牙干细胞移植组(Geth)的报告

2025-09-260
PRE
Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022—Epidemiology and Impact on Clinical Events

2015年至2022年加泰罗尼亚地区镰状细胞病的新生儿筛查——流行病学及其对临床事件的影响

2025-08-210
PRE
Hematopoietic stem cell gene therapy for mucopolysaccharidosis type I-Hurler syndrome (OTL-203): Interim skeletal, neurological and systemic outcomes from a phase I/II study
2025-02-010
PRE
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee

Car-t细胞治疗时代儿童急性淋巴细胞白血病移植后复发.Espanol de Trasplante hepopoyetico y Terapia Celular (geth-tc) 儿科委员会的多中心分析

2024-12-010
PRE
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia

范可尼贫血中突变类型和染色体脆性的预后意义

2024-11-190
OAAI
Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study

比较接受两种不同类型人抗T淋巴细胞球蛋白的儿童急性淋巴细胞白血病(ALL)患者,在造血干细胞移植前的结果:国际前瞻性论坛研究的结果

BLOOD
IF23.1
2024-11-050
PRE
Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events

加泰罗尼亚2015年和2022的新生儿镰状细胞病筛查-流行病学及其对临床事件的影响

2024-10-030
OAAI
Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Espanol de Trasplante Hematopoyetico)
2024-10-011
PRE